Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Leukemia & Lymphoma|July 28, 2012
Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemiaYvette L Kasamon, Robert A Brodsky, Michael J Borowitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
Nuclear Medicine and Biology|May 7, 2016
[(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infectionXiaoyan M Zhang, Halle H Zhang, Patrick McLeroth, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2020
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic CancerJacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, et al.
Ebiomedicine|December 13, 2024
Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion studyJustine Yang Bruce, Adam Burr, Randall J Kimple, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2023
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation TherapyBradford S Hoppe, Kathleen M McCarten, Qinglin Pei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2012
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancerSteve Y Cho, Kenneth L Gage, Ronnie C Mease, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMichael J Morris, Steven P Rowe, Michael A Gorin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2021
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or EnzalutamideKatherine A Zukotynski, Urban Emmenegger, Sebastien Hotte, et al.
Pageof 9